Term ends May 14, 2039 · Medium confidence
20-year base term ends May 14, 2039
Why Medium: The disclaimer's references carry disclaimers of their own not yet read (US 11,535,658, US 11,981,716), so the cap could be lower.
May 14, 2019
May 14, 2039
Jan 27, 2026
This patent's term runs 87 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 0 of 3 maintenance fees are paid so far. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts May 14, 2019, when application PCT/US2019/032321, the earliest non-provisional in its chain, was filed (this one was filed Oct 9, 2022) | May 14, 2039 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +87 days, USPTO patent term adjustment record | Aug 9, 2039 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,696,724, US 11,352,403, US 11,535,658, US 11,981,716) | capped to May 14, 2039 | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | May 14, 2039 | Medium confidence |
This family
| Application PCT/US2019/032321 | PCT application no patent term | no patent term |
| US 10,696,724 | In force May 2039 | May 2039 |
| US 11,352,403 | In force May 2039 | May 2039 |
| US 11,981,716 | In force no later than Jul 2039 | no later than Jul 2039 |
| US 11,535,658 | In force no later than May 2039 | no later than May 2039 |
| US 12,534,505 | this patent May 2039 | May 2039 |
| Application 19/423,455 | Pending not computed | not computed |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Oct 23, 2022 Reel 61505, frame 831 | Winston, William | Werewolf Therapeutics, Inc. | Assignment of Assignor's Interest |
| Oct 23, 2022 Reel 61505, frame 839 | Seidel-dugan, Cynthia | Werewolf Therapeutics, Inc. | Assignment of Assignor's Interest |
| Oct 23, 2022 Reel 61505, frame 845 | Hicklin, Daniel | Werewolf Therapeutics, Inc. | Assignment of Assignor's Interest |
| Oct 23, 2022 Reel 61505, frame 850 | Baeuerle, Patrick | Werewolf Therapeutics, Inc. | Assignment of Assignor's Interest |
| Oct 23, 2022 Reel 61505, frame 856 | Salmeron Garcia, Jose Andres | Werewolf Therapeutics, Inc. | Assignment of Assignor's Interest |
| Oct 23, 2022 Reel 61505, frame 861 | Brodkin, Heather | Werewolf Therapeutics, Inc. | Assignment of Assignor's Interest |
| Oct 23, 2022 Reel 61505, frame 871 | Evnin, Luke | MPM Asset Management LLC | Assignment of Assignor's Interest |
| Oct 23, 2022 Reel 61505, frame 879 | Bhaskar, Vinay | MPM Asset Management LLC | Assignment of Assignor's Interest |
| Oct 23, 2022 Reel 61505, frame 884 | MPM Asset Management LLC | Werewolf Therapeutics, Inc. | Assignment of Assignor's Interest |
| Oct 15, 2026 Reel 76677, frame 66 | Werewolf Therapeutics, Inc. | EMD Serono Research & Development Institute, Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 10,696,724, US 11,352,403, US 11,535,658, US 11,981,716.